Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2019
Source ID
10.1016/j.omto.2018.12.004

Entities

People

  • Jonathan A. Hensel
  • Reading Ashton
  • Selvarangan Ponnazhagan
  • Vinayak Khattar

Organizations

  • National Institutes of Health
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech